Mass Balance Study of [14C] LPM3770164 in Healthy Participants

Summary

This is a phase 1, single-center, single-dose, open-label mass-balance study to evaluate radioactive recovery rate, radioactive PK characteristics, metabolite identification, and to observe the safety in healthy male subjects of \[14C\] LPM3770164.

Timeline

Start

2026-04-30

Primary completion

2026-06-30

Completion

2026-07-30

Drugs

Indications